Tag: BMO Capital
Okta About to Refill its Bearish Gap
On March 2, we noted, “Keep an eye on Okta (OKTA). After Cowen analysts upgraded the stock to an outperform rating from market perform,...
Weakness in Bristol Myers Squibb is a Big Opportunity
Bristol Myers Squibb (BMY) is on the move.
After plummeting from about $68 to a low of $54.60, the oversold stock is just starting to...